BSI-201 News
Most Popular BSI-201 Story
Hungry Sanofi snaps up BiPar in $500M deal
Following through on its plans to buy up small and mid-sized drug developers, Sanofi-Aventis struck a deal to buy the U.S. cancer specialist BiPar Sciences for up to $500 million. The money is being Read more...
Latest Headlines
- April 15, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
